News & Events

03/11/09 MitoProd presents the conception of its ciRNA® (circular interfering RNA) and its production strategy at Discovery on Target in Boston. 

06/10/09 - MitoProd Presents Data from Manufacturing technology and circular interfering RNA at RNAi summit in San Francisco

03/18/09 - Sigma-Aldrich enters distribution agreement with MitoProd, to Offer Customized Long RNA Oligonucleotides.

01/27/09 MitoProd SA today announced the completion of the conception and patenting of a new class of interfering RNA, called ciRNA®, designed for the Health Industry.

01/16/2009 MitoProd has been granted a European patent for its proprietary technology for RNA manufacturing

05/16/2008 MitoProd secures 0,5 M€ from the Regional Council of Aquitaine for the RNAGENIX program that was launched in October 2007 with Flamel Technologies SA (NASQDAQ:FLML)

09/30/2007 MitoProd signs an exclusive agreement with AR Brown Co., Ltd for the commercialization of custom RNA synthesis in Japan 

08/07/2007 MitoProd SA announces that its activities have been certified by Bureau Veritas Certification to ISO 9001: 2000.

 07/17/07 MitoProd SA and Flamel technologies (NASDAQ: FLML) launch RNAGENIX, with the MCMP laboratory (University of Bordeaux)

02/28/07 MitoProd SA received an innovation grant from Oséo Innovation agency to go ahead its research program.

12/16/06 MitoProd moves to larger permises on the Carreire campus of Bordeaux. The new facility is based on the fonctional genomic plateforme.

07/04/06 Just one year after their initial capital increase of 142 K€, MitoProd has entered a decisive phase in the development of its activities.

06/07/06 MitoProd received the "Coup de coeur" price at the Aquitaine Venturing Show.

11/21/05 One year after its creation, MitoProd SA relocates from the scientific founders’ laboratory to larger facilities, close to the Bordeaux University's hospital.

12/17/04 MitoProd SA signed an exclusive licensing contract with the national center for scientific research (CNRS) and the University Victor Segalen - Bordeaux 2, for the exploitation of the fermentation based RNA production technology.

12/14/04 MitoProd SA has obtained the status of Young Innovating Company (JEI) from the french economy and finance minister.

12/03/04 MitoProd SA received 165 k€ from the National Agency for the Research Valorization (ANVAR - Agence nationale de valorisation de la recherche) to finance its next innovation program.

11/25/04 MitoProd SA received 140 k€ from the Conseil régional d'Aquitaine for « the creation of a production devoted company » .

10/26/04 MitoProd SA is increasing its shareholders’ equity to 142 k€ by fund rising.

09/06/04 After technology valorization steps, the developers of the MitoProd Project are creating a company (SA for Société Anonyme) with the aim of utilizing the technological process developed in the lab for industrial and commercial purposes.

10/22/03 MitoProd Project is entering the Incubateur Régional d’Aquitaine (IRA).